Target has raised its dividend every year for over five decades, but surging capital spending and tightening free cash flow are now putting that streak in a precarious spot. Whether the 3% yield is…
Before a single public share trades, Anthropic is already giving a slice of itself away, and the structure means the better the stock performs, the more new shareholders lose to the fund.
HPE just posted its worst week ever after a single analyst downgrade, yet its earnings are surging and its backlog hit a record high. The real question is whether the market sees a danger…
Jim Cramer called out two storage giants sitting on massive year-to-date gains as the most dangerous stocks to own if one key spending trend reverses, and the math behind their profits makes the risk…
CoreWeave and Nebius both sold every GPU they brought online in Q2, yet one carries billions in debt while the other runs on customer prepayments. A credit squeeze could expose that difference fast.
Salesforce is building an AI agent empire while its stock sits near multi-year lows, and the math behind a potential 184% gain by 2030 comes down to whether three very specific things happen in…
Alphabet grows like an AI startup yet trades closer to a sleepy ad business, and that gap between perception and reality raises a pointed question about which Magnificent 7 stock carries the most favorable…
ARK Investment Management just published a Tesla price target so far above Wall Street consensus that it practically requires two entirely new industries to exist at massive scale by 2031, and one of them…
Six high-yield income stocks are flashing elevated payouts right now partly because their prices have been falling hard, and that tension between danger and opportunity is exactly what retirees living off a portfolio need…
McDonald's, Darden, and Yum! Brands all convert daily foot traffic into shareholder income, but only one of them kept raising its dividend when dining rooms went dark and customers disappeared.
NVIDIA collects a check whether hyperscalers borrow, issue stock, or drain their cash reserves, but Meta faces a funding squeeze that could reshape what shareholders actually own. The size of one expected equity offering…
Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction until you see what that same bet returned over five years.
Retirees flock to PIMCO's PDI for its generous monthly checks, but stacking it against a straightforward dividend ETF reveals a total-return gap that decades of income payments struggle to explain.
PFF's headline yield draws retirees chasing income, but the fund sponsor's own performance table tells a different story about what investors actually kept after five years of payouts.
Three funds hold government-backed bonds, yet their five-year losses tell a wildly different story. Understanding why one swings so much harder could change which one belongs in your portfolio.
